期刊
ADVANCED DRUG DELIVERY REVIEWS
卷 127, 期 -, 页码 138-166出版社
ELSEVIER
DOI: 10.1016/j.addr.2018.04.008
关键词
Wound healing; Drug delivery; Transdermal delivery; Microtechnologies; Nanotechnologies
资金
- National Institutes of Health [HL092836, DE019024, EB012597, AR057837, DE021468, HL099073, EB008392]
- University of Nebraska, Lincoln
- Belgian American Educational Foundation (BAEF)
- King Baudouin Foundation (KBS)
- National Centre for Research and Development [STRATEGMED1/233224/10/NCBR/2014]
- Nebraska Tobacco Settlement Biomedical Research Enhancement Funds
Chronic, non-healing wounds place a significant burden on patients and healthcare systems, resulting in impaired mobility, limb amputation, or even death. Chronic wounds result from a disruption in the highly orchestrated cascade of events involved in wound closure. Significant advances in our understanding of the pathophysiology of chronic wounds have resulted in the development of drugs designed to target different aspects of the impaired processes. However, the hostility of the wound environment rich in degradative enzymes and its elevated pH, combined with differences in the time scales of different physiological processes involved in tissue regeneration require the use of effective drug delivery systems. In this review, we will first discuss the pathophysiology of chronic wounds and then the materials used for engineering drug delivery systems. Different passive and active drug delivery systems used in wound care will be reviewed. In addition, the architecture of the delivery platform and its ability to modulate drug delivery are discussed. Emerging technologies and the opportunities for engineering more effective wound care devices are also highlighted. (C) 2018 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据